Tech Mahindra (NSE: TECHM), a leading global provider of technology consulting and digital solutions to enterprises across ...

The US pharmacovigilance market is expanding due to rising chronic diseases, stringent FDA regulations, and AI-driven ...

Tech Mahindra and NVIDIA unveil an AI-powered pharmacovigilance solution to enhance drug safety, reducing delays, improving ...

In 2021, the American Society of Pharmacovigilance (ASP) launched the Fourth Cause Campaign to raise awareness that adverse drug events (ADEs) were the fourth leading cause of death in the United ...

announced a pharmacovigilance (PV) autonomous solution built with NVIDIA AI software to advance drug safety management. The transformative solution leverages agentic artificial intelligence (AI ...

In the era of digital health transformation, generative AI (GenAI) has emerged as a breakthrough technology in pharmacovigilance, the science dedicated to ensuring drug safety. Pharmacovigilance ...

In a move to enhance patient safety and strengthen pharmacovigilance, the All India Institute of Medical Sciences (AIIMS), ...